Janssen (JNJ) Receives Two U.S. FDA Approvals For SIMPONI ARIA For Treatment of Adults With Active PsA or Active Ankylosing Spondylitis
Tweet Send to a Friend
Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved SIMPONI ARIA® (golimumab), the only ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE